Overweight/Obesity-related Polycystic Ovary Syndrome
Conditions
Interventions
Combined head and body acupuncture group:The scalp-body acupuncture combination group included the following protocol: Scalp Acupuncture: Yu's Scalp Acupuncture, Frontal Region Cluster Needling:
Procedure: Patients assumed different postures (sitting, prone, supine) as required to expose the head, lower back, and abdomen. Routine disinfection was performed with 75% alcohol. After needles wer
Treatment Course: The total treatment duration was 12 weeks, with sessions administered 3 times per week
Materials: Acupuncture Needles: Disposable sterile acupuncture needles, Huatuo brand (Chengzhen series), specifications 30 × 40 mm or 30 × 75 mm. Electroacupuncture Device: Huatuo brand SDZ-IIB
Body Acupuncture Group:Body Acupuncture: Acupoint Group 1: Single points: Qihai (CV6), Guanyuan (CV4), Zhongji (CV3) Bilateral points: Daimai (GB26), Tianshu (ST25), Zigong (CA-CV1, extra poi
Sponsors
Beijing University of Chinese Medicine Dongzhimen Hospital
Eligibility
Sex/Gender
Female
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: 1: Female, aged 18 to 40 years 2: Meets the above diagnostic criteria for polycystic ovary syndrome; 3: Meet the above diagnostic criteria for overweight/obesity and abdominal obesity; 4: At least one menstrual period in the last 6 months without hormonal intervention, but in the last 12 months 5: The subjects themselves gave informed consent and voluntarily signed an informed consent form
Exclusion criteria
Exclusion criteria: 1: Patients who are pregnant, breastfeeding, perimenopausal, or have a history of pregnancy, miscarriage, or childbirth in the last 30 days; 2: Patients who are being treated with Chinese or Western medications or other modalities; 3: Those with pituitary disorders, thyroid disorders, adrenal disorders, diabetes mellitus, hyperprolactinemia (=25 ng/ml), and other endocrine disorders that affect the menstrual cycle and endocrine disorders; 4: Patients with severe cardiovascular, cerebrovascular, hematologic, malignant neoplasm, psychiatric diseases, and abnormalities of liver and kidney functions; 5: Patients who have received disease-related herbal formulas, proprietary Chinese medicines, or acupuncture within the last 2 months; 6: Patients who have taken other medications in the last 2 months that are known to affect metabolism or weight, such as metformin and hormonal contraceptives; 7: Have had bariatric surgery in the last 1 year or are in a period of dramatic weight loss; 8: Patients with contraindications to acupuncture; 9: Patients with metal allergies or acupuncture intolerance; 10: Patients who are unable to cooperate with the frequency and course of acupuncture treatments.
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| Restore ovulation rate; | — |
Secondary
| Measure | Time frame |
|---|---|
| serum sex hormone level;blood lipid profile;Weight, Waist Circumference, Hip Circumference, Waist-to-Hip Ratio, Skinfold Thickness, BMI, Body Roundness Index (BRI);Modified FerrimanGallway Hairiness Score;Comprehensive Grading System for Acne;Polycystic Ovaries Quality of Life Questionnaire;Quality of life table SF-36;Depression, Anxiety Self-Rating Scale; | — |
Countries
China
Contacts
Public ContactJinxia Ni
Beijing University of Chinese Medicine Dongzhimen Hospital
Outcome results
None listed